BERTopic results plotkins vaccines

Topic 0
  Auto Label:        Rotavirus
  Descriptive Label: Rotavirus
  Keywords:          rotavirus, immunity rotavirus, diarrhea, controlled clinical, colostrum, infants, clinical trial, rotavirus infection, rotavirus vaccine, oral rotavirus
  Summary:           Rotavirus represents an enteric viral pathogen wherein pro- tective passive immunotherapy has been demonstrated. In one example of postexposure treatment in infants, oral administration of hyperimmune antibody was able to efficiently reduce rota- virus shedding compared to placebo controls.

Topic 1
  Auto Label:        Antibody
  Descriptive Label: Antibody – Immunotherapy
  Keywords:          life, half life, display, half, specificity, polyclonal antibodies, region, antibody- based, antibody-, rare
  Summary:           Before antibiotics, antibody-based therapy was the only option available for combating many bacterial diseases. Today, most commercial forms of antibody- based immunotherapy for infectious disease still rely on poly- clonal antibodies of human or animal origin.

Topic 2
  Auto Label:        Hiv
  Descriptive Label: Hiv
  Keywords:          broadly, antiretroviral, single, broadly neutralizing, rebound, viremia, antiretroviral drugs, viral load, nature, load
  Summary:           A recent Phase I clinical trial involving a single administration of a broadly neutralizing antibody, 3BNC117, has renewed interest in the study of passive immunotherapy for HIV pre- vention and therapeutic intervention. At a dose of 10 or 30 mg/kg, patient viral load was reduced by up to 2.5 log10 (average decline: 1.48 log10)

Topic 3
  Auto Label:        Pathogen
  Descriptive Label: Pathogen
  Keywords:          cholera, salmonella, yolk, cholera serum, - cholera, new anti, yolk antibodies, experimentally, egg, egg yolk
  Summary:           E. coli is a significant enteric pathogen.

Topic 4
  Auto Label:        Staphylococcus
  Descriptive Label: Staphylococcus
  Keywords:          staphylococcus, staphylococcus aureus, aureus, multicenter, treatment staphylococcus, staphylococcus bacteremia, multicenter study, mice staphylococcus, bacteremia, targeting
  Summary:           A human monoclonal antibody targeting the conserved staphylococcal antigen IsaA protects mice against Staphylitis aureus bacte- remia. A blinded, random- ized, multicenter study of an intravenous StAPHylococcus a Aureus immune globulin.

Topic 5
  Auto Label:        Lassa
  Descriptive Label: Lassa
  Keywords:          survived, lassa, %, % patients, fever, virologically, infected guinea, patients survived, days hospitalization, patients virologically
  Summary:           Junin virus and untreated cases result in 15% to 40% mortality. Convalescent serum is protective in animal models of Junin infection.

Topic 6
  Auto Label:        Immunodeficiency
  Descriptive Label: Immunodeficiency – Macaques
  Keywords:          macaques, simian, immunodeficiency virus, shiv, block, pathogenic simian, potent, simian human, pathogenic, simian immunodeficiency
  Summary:           Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro.

Topic 7
  Auto Label:        Cytomegalovirus
  Descriptive Label: Cytomegalovirus
  Keywords:          cytomegalovirus, transplant, sir, lymphoma, hodgkin, cmv, - hodgkin, recipients, sir p, cytomegalovirus infection
  Summary:           cytomegalovirus (CMV) is a leading cause of posttransplant non- Hodgkin lymphoma resulting from the uncontrolled prolif- eration of EBV-infected B lymphocytes in patients undergoing immunosuppressive therapies. In a large retrospective study involving 44,828 kidney transplant patients, the effect of pro- phylactic treatment for CMV on posttrans- plant incidence of non-Hodgkin lymphomas was examined.

Topic 8
  Auto Label:        Smallpox
  Descriptive Label: Smallpox
  Keywords:          smallpox, contacts, hemorrhagic smallpox, smallpox vaccination, administered smallpox, cases %, shortly, postexposure vaccination, postexposure, hemorrhagic
  Summary:           Vaccinia-immune gammaglobulin (VIG) was administered to smallpox contacts prior to disease onset in addition to postexposure vaccination (i.e., standard of care) The number of smallpox cases was reduced by 70% compared to contacts who received postex exposure smallpox vaccination alone.

Topic 9
  Auto Label:        Hepatitis
  Descriptive Label: Hepatitis – Globulin
  Keywords:          hepatitis, infectious hepatitis, gamma globulin, globulin jama, hepatitis gamma, gamma, infectious, stokes, brother use, mediterranean theater
  Summary:           Gamma globulin was used in the Mediterranean theater of operations I. It was also used to control chicken pox in a convalescent hospital for children.

Topic 10
  Auto Label:        Botulism
  Descriptive Label: Botulism
  Keywords:          botulism, botulinum, botu-, botulism immune, protection botulinum, immune globulin, outcome, s38 neutralizing, botulinum toxins, inhalation model
  Summary:           Botulinum neurotoxin neutralizing activity of immune globulin (IG) purified from clinical volunteers vaccinated with recombinant botulinum vaccine (rBV A/B)

Topic 11
  Auto Label:        Malaria
  Descriptive Label: Malaria
  Keywords:          tion monocytes, vivo assess-, invasion, coopera-, monocytes, plasmodium, act, sabchareon, acquired, observations antitetanus
  Summary:           Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro. Gamma-globulin and acquired immunity to human malaria.

Topic 12
  Auto Label:        Pneumonia
  Descriptive Label: Pneumonia
  Keywords:          pneumonia, treatment lobar, pneumococcal pneumonia, lobar pneumonia, lobar, pneumococcus, pneumococcal, lung, epithelial cells, murine nasopharyngeal
  Summary:           InfectImmun.2004;72:4534- 4540. Human antibod- ies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization.

Topic 13
  Auto Label:        Antibody
  Descriptive Label: Antibody – Influenzae
  Keywords:          influenzae, influenzae type, ambrosino, haemophilus, haemophilus influenzae, type, inhibiting antibody, recurrent, poor, influenzae extracellular
  Summary:           H. influenzae type b (Hib) is an extracellular gram-negative.

Topic 14
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Antibodies
  Keywords:          plague, f1, bubonic, yersiniae, brubaker, infect brubaker, immunity yersiniae, antigens infect, antigen, recombinant
  Summary:           Human anti-plague mono- clonal antibodies protect mice from Yersinia pestis in a bubonic plague model. Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens.

Topic 15
  Auto Label:        Tuberculosis
  Descriptive Label: Tuberculosis – Mycobacterium
  Keywords:          showed, sputum, mycobacterium tuberculosis, mycobacterium, tuberculosis, antibody mediated, % animals, survival, alive, tubercu-
  Summary:           Mycobacterium tuberculosis is another intracellular bacte- of the most common human diseases. It is estimated to infect up to one-third of the world’s population.

Topic 16
  Auto Label:        Palivizumab
  Descriptive Label: Palivizumab – Rsvs
  Keywords:          hospitalizations, respiratory syncytial, syncytial virus, syncytial, rsv-, premature infants, premature, palivizumab, hospitalization respiratory, congenital heart
  Summary:           Palivizumab was shown to significantly improve clinical outcome by reducing RSV- associated hospitalizations of children with congenital heart disease by 45%. Among premature infants or those with bronchopulmonary dysplasia, RSVs-associated hospitalizations were reduced by 55%.

Topic 17
  Auto Label:        Measles
  Descriptive Label: Measles – Immunization
  Keywords:          measles, prophylaxis measles, serum prophylaxis, measles convalescent, exposure, preventing, bacterial anti, epidemic %, % exposed, state
  Summary:           During a measles epidemic in 1931–1932, 72% of exposed individuals who received no passive immunization contracted measles. If convalescent serum was administered within 10 days of exposure, the attack rate was reduced to 16% (n = 219) whereas if therapy was not initi- ated until 12 to 16 days postexposure, approximately 80% of those exposed contracted the disease.

Topic 18
  Auto Label:        Hcv1
  Descriptive Label: Hcv1
  Keywords:          humanized antibody, body, anti- body, humanized, e1636, neutralize homologous, antibodies neutralize, therapeutic antibodies, development therapeutic, sukupolvi development
  Summary:           Chikungunya viruses that escape monoclonal antibody therapy are clinically attenuated, stable, and not purified in mosquitoes. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Topic 19
  Auto Label:        Antigenic
  Descriptive Label: Antigenic
  Keywords:          sars, respiratory syndrome, coronavirus, acute respiratory, severe acute, human monoclonal, roberts, model a16, infections human, golden
  Summary:           Human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (SARS) coronavirus S protein neutralizes the virus in rhesus macaque SARS model.

Topic 20
  Auto Label:        Hiviglob
  Descriptive Label: Hiviglob
  Keywords:          intravenous immune, globulin therapy, intravenous, infected pregnant, s56, human developments, child transmission, effect viral, developments, 10(9)/l effect
  Summary:           The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. Effect on viral, opportunistic, and bacte- rial infections.

Topic 21
  Auto Label:        Pertussis
  Descriptive Label: Pertussis – Vaccination
  Keywords:          pertussis, mothers, newborn infants, pertussis vaccina-, maternal pertussis, age, maternal, vaccination, newborn, e.g.
  Summary:           Maternally derived IgG protects against respiratory infections involving viral (e.g., influenza) or bacterial pathogens. The current recommendations for the vaccination of pregnant mothers against B.

Topic 22
  Auto Label:        Fever
  Descriptive Label: Fever – Immunity
  Keywords:          yellow fever, yellow, fever, infections yellow, 17d, 17d yellow, laboratory, bj protection, protection monkeys, fever dengue
  Summary:           Passive protection by mono- clonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. The duration of passive immunity in Yellow Fever.

Topic 23
  Auto Label:        Influenza
  Descriptive Label: Influenza – Tection
  Keywords:          influenza, immunity influenza, intern, serum nasal, clements serum, vaccines laboratory, tection clements, chest, laboratory indices, nasal wash
  Summary:           1. Laboratory indices of pro- tection.

Topic 24
  Auto Label:        Antiviral
  Descriptive Label: Antiviral
  Keywords:          intravenous immunoglobulin, israeli, immunodefi- cient, transplant recip-, possible benefit, therapy lung, benefit intravenous, virus vaccine, gershoni, infect niven
  Summary:           The growth and potential of human antiviral monoclonal antibody therapeutics. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodefi- cient mice.

Topic 25
  Auto Label:        Pseudomonas
  Descriptive Label: Pseudomonas
  Keywords:          pseudomonas, - pcrv, pcrv, resistant, multidrug, multidrug resistant, antibiotic, growing coupled, fewer new, salmo- nella
  Summary:           Antibiotic resistance among clinically relevant bacteria is a growing concern. Fewer new antibiotics are moving through the drug pipe- line,122,123.

Topic 26
  Auto Label:        Meader
  Descriptive Label: Meader
  Keywords:          cough, whooping, whooping cough, nielsen, blood whooping, meader, replacement immunol, history replacement, sharp, replacement
  Summary:           Use of convalescent blood in whooping cough with a review of the literature. Am J Dis Child 1935;50(4): 918-928.

Topic 27
  Auto Label:        Poliomyelitis
  Descriptive Label: Poliomyelitis – Polio
  Keywords:          convalescent serum, convalescent, use convalescent, seventh, seventh note, mckenzie m., bell, resume results, note active, therapy convalescent
  Summary:           The therapeutic use of convalescent serum in polio- myelitis. Cal West Med.

Topic 28
  Auto Label:        Rubella
  Descriptive Label: Rubella
  Keywords:          rubella, scarlet, scarlet fever, fever jama, vaccination virus, immunoglobulin intranasal, infection rubella, intranasal infection, epidemic barrow, immunization rubella
  Summary:           JAMA 1930;94(9):622-625. Rubella epidemic, 1964: effect on 6,000 pregnancies.

Topic 29
  Auto Label:        Meningococcus
  Descriptive Label: Meningococcus
  Keywords:          infant rat, meningococcal, class, rat, induced local, years priming, der anti-, priming systemically, anticryptococcal, perfect
  Summary:           Meningococcal sero- group C conjugate booster vaccination nine years after priming systemically induced local immunity and saliva as potential sur- veillance tool. Vaccine.

Topic 30
  Auto Label:        Measles
  Descriptive Label: Measles – Immunoglobulin
  Keywords:          measles, contracted, contracted measles, attenuation measles, measles virus, titer, lots, human serum, attenuation, serum globulin
  Summary:           In a study published in 1945 involving 1024 cases of measles exposure, 36% of the individuals who received immunother- apy within 0 to 2 days of exposure contracted measles. The titer of virus-specific antibodies will often differ between lots of polyclonal immunoglobulin preparations (see Table 8.2).

Topic 31
  Auto Label:        Antibody
  Descriptive Label: Antibody – Encephalitis
  Keywords:          encephalitis, japanese encephalitis, borne, japanese, bogdahn, monkeys japanese, encepha-, litis, hinkel, ks
  Summary:           Mice, goats, and monkeys can be protected against Japanese encephalitis with monoclonal antibodies. A humanized murine antibody protects mice either before or after challenge with virulent Venezuelan equine encephalomyelitis virus.

Topic 32
  Auto Label:        Rabies
  Descriptive Label: Rabies
  Keywords:          rabies, - rabies, rabies immune, rabies serum, wolf, organ warrell, wolf organ, combination human, supporting clinical, persons bitten
  Summary:           Habel K. Antiserum in the prophylaxis of rabies.

Topic 33
  Auto Label:        1932
  Descriptive Label: 1932
  Keywords:          jama jama, jama, , , , , , , , 
  Summary:           JAMA 1937;

Topic 34
  Auto Label:        Shigellae
  Descriptive Label: Shigellae
  Keywords:          shigellae, neonatal mice, shigellosis, serotype, outer, trial diatr, confer passive, shigellae confer, vesicles shigellae, children double
  Summary:           Multi-serotype outer mem- brane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis.

Topic 35
  Auto Label:        Candidiasis
  Descriptive Label: Candidiasis
  Keywords:          vaginal, candidiasis, vaginal infection, vaccine monoclonal, enhance mouse, enhance, mouse resistance, resistance, chaves m., m. immunoprotection
  Summary:           Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.

Topic 36
  Auto Label:        Technology
  Descriptive Label: Technology
  Keywords:          passive immunization, like, advanced substantially, shift, progress, prozone, paradigm, substantially, necessarily, immunization immunol
  Summary:           Passive Immunization Technology has advanced substantially in the more than a decade.

Topic 37
  Auto Label:        Sepsis
  Descriptive Label: Sepsis
  Keywords:          sepsis, neonatal sepsis, kirkpatrick treatment, pollock role, shock critically, critically ill, roadmap, exacer-, bations, pulmonol
  Summary:           Pseudomonas hyperim- mune globulin passive immunotherapy for pulmonary exacer- bations in cystic fibrosis. Sepsis: a roadmap for future research.

Topic 38
  Auto Label:        Cryptosporidiosis
  Descriptive Label: Cryptosporidiosis
  Keywords:          cryptosporidiosis, cryptosporidium, cl, sl mosier, healthy volunteers, mice severe, - cryptosporidium, chappell cl, effect bovine, cl prophylactic
  Summary:           Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Topic 39
  Auto Label:        Influenza
  Descriptive Label: Influenza – Immunity
  Keywords:          maternal, infants, mothers, maternal antibodies, months, cough infants, infants younger, immunization mothers, lack functional, immunity common
  Summary:           In a comprehensive study involving the analysis of anti- bodies to 16 viruses using samples from 58,500 patients, the relationship between maternal immunity and infant immu- nity is clear. Immunity to less-common viral pathogens, such as influenza B, was relatively low among infants and adults in the cohorts examined in 1971–1972, but higher among those sampled in 1973–1974,1975–1976, and 1977– 1978.

Topic 40
  Auto Label:        Fever
  Descriptive Label: Fever – Hemorrhagic
  Keywords:          argentine, argentine hemorrhagic, hemorrhagic fever, treatment argentine, hemorrhagic, fever, damilano, protection guinea, haemorrhagic fever, ciation
  Summary:           Argentine hemorrhagic fever is caused by infection with the Enria DA. Treatment of Argentine hem- orrhagic fever.

Topic 41
  Auto Label:        Antibiotics
  Descriptive Label: Antibiotics
  Keywords:          serum therapy, antibiotics, behring, immunology serum, philosophical thera-, therapy american, pie der, american philosophical, der collected, thera- pie
  Summary:           Emil von Behring and serum therapy. Microbes Infect.

Topic 42
  Auto Label:        Diphtheria
  Descriptive Label: Diphtheria – Diphtherie
  Keywords:          concerning, adopted, adopted use, intravenous injection, minkenhof vink, recent epidemic, vink intravenous, medical school, injection recent, therapy organ
  Summary:           Treatment of children suffering from diphtheria with ‘diphtherie serum’. The recent epidemic of diphTheria in the Johns Hopkins hospital and medical school.

Topic 43
  Auto Label:        Influenzal
  Descriptive Label: Influenzal
  Keywords:          rabbit, sulfonamide, rabbit serum, influenzae, immunization early, observation, important human, neter, edmonds, pneumococcic
  Summary:           Early reports described the use of concentrated rabbit immune serum as a successful adjunct therapy to sulfonamide. A full course of serum therapy (in addition to antibiotics) was able to reduce mortality to 14% (3 of 19) when compared to 78% mortality rate (7 of 9) in those patients only receiving sul- fonamides.

Topic 44
  Auto Label:        Immunization
  Descriptive Label: Immunization
  Keywords:          diphtheria, behring, animals, successfully, tetanus, work, toxin, tetanus toxin, setting, lethal dose
  Summary:           Passive immunization, passive immunity, and passive immu- notherapy all refer to the transfer of antibodies to an unpro- tected individual for the prevention or treatment of disease. In 1901 Emil von Behring was awarded the first Nobel Prize for Physiology or Medicine for the discovery of this important medical intervention.

Topic 45
  Auto Label:        Tularemia
  Descriptive Label: Tularemia
  Keywords:          tularemia, months recovery, recovery, equine received, summary, comparative study, equine, antibiotic, months, received
  Summary:           Passive immunotherapy was the only option for clinical treat- ment of most bacterial infections including Francisella tularen- sis. The untreated tularemia cases required an average of 3.78 months to recover.

Topic 46
  Auto Label:        Antibodies
  Descriptive Label: Antibodies – Cows
  Keywords:          subjects, diarrhea, coli, hyperimmunized, cows, daily, treated subjects, following challenge, subjects received, placebo subjects
  Summary:           Pregnant cows were hyperimmunized with a large number of enterotoxigenic O serogroups. Milk collected during the first 10 days of lactation was purified, concentrated, lyophilized, and formulated for oral administration.

Topic 47
  Auto Label:        Vaccine
  Descriptive Label: Vaccine – Vaccinia
  Keywords:          mabs, fogg, a27 protein, protein protection, levels vitro, antibody a27, fogg disparity, - h3, mice intranasal, intranasal challenge
  Summary:           Vaccinia virus B5 protein neutralizes vaccinia and smallpox viruses and protect mice against vaccinia virus. Vaccinia immune globulin is used to treat SCID mice.

Topic 48
  Auto Label:        Papillomavirus
  Descriptive Label: Papillomavirus
  Keywords:          genital, trachomatis, membrane protein, major outer, chlamydial genital, chlamydial, chlamydia, genital challenge, chlamydia trachomatis, major
  Summary:           Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.

Topic 49
  Auto Label:        Staphylococcal
  Descriptive Label: Staphylococcal
  Keywords:          infec-, birth weight, weight infants, low birth, weight, infec- tion, birth, immunoglobulins, low, explain considered
  Summary:           The ability to penetrate mucosal sites and nonlymphoid tissues is likely to explain why it is often considered the best immunoglobulin isotype for routine passive immunization. It has shown clinical benefit ranging from reduced clinical symptoms to nearly complete protection from lethal infection in a number of infectious disease models.

Topic 50
  Auto Label:        Toxoplasmosis
  Descriptive Label: Toxoplasmosis
  Keywords:          cells, t cells, toxoplasma, toxoplasmosis, t, mediated protection, bacteria, intracellular, antibody mediated, number
  Summary:           In 1890 Behring demonstrated that immune serum therapy could protect against diphtheria. Today a number of passive immunotherapy products are in clinical use.

Topic 51
  Auto Label:        Tetanus
  Descriptive Label: Tetanus
  Keywords:          tetanus, treatment tetanus, tetanus antitoxin, military, molecule reliable, equine tetanus, analysis health, tetanus meta, occurred home, outcome six-
  Summary:           The treatment of tetanus with antitoxin has long been controversial. Tetanus is the most common cause of death from tetanus in the United States.

Topic 52
  Auto Label:        Anthrax
  Descriptive Label: Anthrax
  Keywords:          anthrax, antibody therapies, migone subramanian, inhalational, cutaneous, subramanian, migone, septicaemia, anthrax jama, cutaneous anthrax
  Summary:           Raxibacumab for the treatment of inhalational anthrax. N Engl J Med.

Topic 53
  Auto Label:        Immunotherapy
  Descriptive Label: Immunotherapy
  Keywords:          symptomatic disease, improved, highly, disease, symptomatic, prior, antibody therapy, effective, immunotherapy figure, critical parameters
  Summary:           Passive immunotherapy can be highly successful for sufficient for protection or therapeutic intervention of acute or remittent disease. Examples of successful passive immunization approaches may provide a useful framework for developing new and improved vaccines.

Topic 54
  Auto Label:        Ebola
  Descriptive Label: Ebola
  Keywords:          macaques monoclonal, macaques, committee s23, mupapa, infection rhesus, mupapa treatment, cocktail med, med therapeutic, treatment hemorrhagic, blood transfusions
  Summary:           Ebola GP-specific monoclo- nal antibodies protect mice and guinea pigs from lethal Ebola virus infection. Qiu X, Fernando L, Melito PL, et al.

Topic 55
  Auto Label:        Antibody
  Descriptive Label: Antibody – Antibodies
  Keywords:          mg, escape mutants, mutations, escape, syncytial, respiratory syncytial, syncytial virus, epitope, respiratory, mutants
  Summary:           Palivi- zumab has been shown to be effective against respiratory syncytial virus. Monoclonal antibodies can remain effective when used clinically in the long-term as long as they are specific for a stable epitope for that pathogen.

Topic 56
  Auto Label:        Lyme
  Descriptive Label: Lyme
  Keywords:          feigin cherry, cherry, feigin, tr, disease spirochete, disease passive, kj preventing, diseases 6th, pediatric infectious, immunization infect
  Summary:           Passive immunization of hamsters against experimental infection with the Lyme disease spirochete. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, eds.

Topic 57
  Auto Label:        Microbiol
  Descriptive Label: Microbiol
  Keywords:          francisella tularensis, tularensis, francisella, tularemia vaccine, live tularemia, tularemia, live, immunopathogenesis potential, infection sera, p green
  Summary:           Francisella tularensis is a potential agent of biowarfare. It causes tularemia in humans and mice.

Topic 58
  Auto Label:        Hepatitis
  Descriptive Label: Hepatitis – Hcv1
  Keywords:          hbv, transplantation, hepatology, panzees hepatology, negative cirrhotics, viral rebound, antibody mbl, delays hcv, mbl delays, immunoprophy- laxis
  Summary:           Liver transplantation in HBsAg-positive HBV-DNA—negative cirrhotics. Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplant.

Topic 59
  Auto Label:        Antitoxin
  Descriptive Label: Antitoxin
  Keywords:          antitoxin, 1896;26:957, antitoxin scarlet, push science, drug push, 1896;26:957 drug, jama 1896;26:957, antitoxin jama, erysipelas, lewis
  Summary:           Antitoxin versus no antitoxin in scarlet fever. JAMA 1934;103(14

Topic 60
  Auto Label:        Herpes
  Descriptive Label: Herpes
  Keywords:          herpes, herpes infection, cytotoxic, mutants altered, simone c, antibody activity, synthetic, d, dependent cellular, antibody dependent
  Summary:           Antibody alone and combined with acyclovir on neonatal herpes simplex virus infection in guinea pigs. Intravenous immuno- globulins suppress the recurrences of genital herpessimplex virus: a clinical and immunological study.

Topic 61
  Auto Label:        Influenza
  Descriptive Label: Influenza – Pandemic
  Keywords:          global mortality, global, mortality, hist, accounts global, ratory, spanish bull, young chil-, dren systematic, review meta
  Summary:           Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. Johnson NP, Mueller J.

Topic 62
  Auto Label:        Reanalysis
  Descriptive Label: Reanalysis
  Keywords:          parotitis jama, parotitis, reanalysis, lb, epidemic parotitis, prophylaxis epidemic, parodi prophylaxis, lb parodi, guerrero lb, study parotitis
  Summary:           Regan JC. Serum Prophylaxis of epidemic parotitis.

Topic 63
  Auto Label:        Complement
  Descriptive Label: Complement
  Keywords:          fixing, line, complement fixing, complement, prevalence, specific prevalence, viral antigens, age specific, covering period, period
  Summary:           Figure 8.1. Age-specific prevalence of antibodies to mumps, measles, influenza A, and influenza B viruses in patients screened with 16 viral antigens during the years 1971–1978.

Topic 64
  Auto Label:        Bubonique
  Descriptive Label: Bubonique
  Keywords:          pasteur, inst, antirabique, babès v, pasteur babès, bubonique pasteur, médecine bubonique, orient médecine, extrême orient, simond extrême
  Summary:           Yersin A, Calmette A, Borrel A. La peste bubonique (duexiéme note).

Topic 65
  Auto Label:        Streptococcal
  Descriptive Label: Streptococcal – Globulin
  Keywords:          toxic shock, toxic, shock syndrome, streptococcal toxic, shock, streptococcal, therapy streptococcal, comparative observational, syndrome comparative, noglobulin therapy
  Summary:           Darenberg J, Ihendyane N, Sjolin J, et al. Intravenous immuno- globulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

Topic 66
  Auto Label:        Mumps
  Descriptive Label: Mumps
  Keywords:          mumps, mumps child, child, treatment prophylaxis, hess protective, protective therapy, prophylaxis orchitis, therapy mumps, child mumps, orchitis
  Summary:           Hess AF. A protective therapy for mumps.

Topic 67
  Auto Label:        Antibodies
  Descriptive Label: Antibodies – Immunoglobulin
  Keywords:          trans-, utero, transport, gastrointestinal tract, mink, fetus, trans- ferred, ferred, maternal igg, mother
  Summary:           Maternal antibodies represent a natural form of passive immu- notherapy in which the immunoglobulin (Ig) G repertoire of the mother’s preexisting humoral immune response is trans- ferred to the fetus through the placenta. Acquisition of mater- nal antibodies varies widely among mammalian species.

Topic 68
  Auto Label:        Glycoproteins
  Descriptive Label: Glycoproteins
  Keywords:          peters, sters, scand blackburn, blackburn nk, infection syrian, immunol scand, cj active, future peters, nk topological, topological mapping
  Summary:           Antibodies targeting conserved regions of the HCV enve- lope glycoprotein E2.

Topic 69
  Auto Label:        Igg
  Descriptive Label: Igg
  Keywords:          mucosal, upper, antibody titers, igg, influenza, half, titers, tract, prevented pathology, contributor
  Summary:           Serum IgG molecules equilibrate into extravascular space whereas IgM is largely confined to intravascular space. IgM molecules also have a short half-life (5 days14) and are typi- cally of low affinity.

Topic 70
  Auto Label:        Antitiyphoid
  Descriptive Label: Antitiyphoid
  Keywords:          antitiyphoid serum, return past, models infection, diseases a., antitiyphoid, clinical trials, case antibody, past case, trials new, therapies infectious
  Summary:           Casadevall A, Scharff MD. Serum therapy revisited: animal models of infection and development of passive antibody therapy.

Topic 71
  Auto Label:        Streptococcus
  Descriptive Label: Streptococcus – Streptococci
  Keywords:          group, candidate, tribution t, mechanism protection, infect good, induced group, mf mechanism, infection group, protection induced, neous infection
  Summary:           Active and passive immunizations with the streptococcal esterase Sse protect mice against subcuta- neous infection with group A Streptococci.

Topic 72
  Auto Label:        Streptococcal
  Descriptive Label: Streptococcal – Antibody
  Keywords:          streptococcal disease, group streptococcal, streptococcal, disease pt, pt, streptococcal infection, baker, neonatal streptococcal, defi-, susceptibility
  Summary:           Maternal antibody at deliv- ery protects neonates from early onset group B streptococcal disease.

Topic 73
  Auto Label:        Palivizumab
  Descriptive Label: Palivizumab – Virus
  Keywords:          cotton, cotton rats, syncytial virus, syncytial, respiratory syncytial, palivizumab, mutants, rats, virus escape, mutants respiratory
  Summary:           Zhao X, Chen FP, Megaw AG, Sullender WM. Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants.

Topic 74
  Auto Label:        Measles
  Descriptive Label: Measles – Vaccine
  Keywords:          failure, vaccine failure, measles vaccine, measles, months mechanism, survey, ennis, measles vaccination, age measles, appropriate age
  Summary:           Measles vaccine failure. A survey of causes and means of prevention.

Topic 75
  Auto Label:        Immun
  Descriptive Label: Immun
  Keywords:          2000;122(2):143, transfer neutralizing, 89.6pd passive, 2000;122(2):143 89.6pd, scid 2000;122(2):143, immunodeficiencies scid, combined immunodeficiencies, 89.6pd, immunodeficiencies, antibodies infect
  Summary:           Fischer A. Severe combined immunodef

Topic 76
  Auto Label:        Diphtheria
  Descriptive Label: Diphtheria – Antitoxins
  Keywords:          antitoxins, identification, today ., rowley, sevigny, experimental diphtheria, antitoxins experimental, replace, homolo-, gous
  Summary:           Behring’s discovery of diphtheria and tetanus antitoxins. Sevigny LM, Booth BJ, Rowley KJ, et al.

Topic 77
  Auto Label:        Immunotherapie
  Descriptive Label: Immunotherapie
  Keywords:          varicella zoster, zoster immune, varicella, zoster, evidence secondary, syndrome evidence, med syndrome, globulin med, secondary prevention, secondary
  Summary:           Couzi G, Kircher JP. Immunotherapie de la Variole.

Topic 78
  Auto Label:        Poliomyelitis
  Descriptive Label: Poliomyelitis – Globulin
  Keywords:          coriell, prophylactic agent, agent, elitis, therapeutic antiviral, jama coriell, geijer, lactic, coriell prophylactic, diagnoses
  Summary:           Hammon WM, Coriell LL, Wehrle PF, Stokes J Jr. Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis.

Topic 79
  Auto Label:        Enteroviral
  Descriptive Label: Enteroviral
  Keywords:          oral challenge, immu- noglobulin, noglobulin, oral, infections emphasis, protect oral, toxigenic effect, intravenous immu-, purified colonization, challenge toxigenic
  Summary:           Milk immuno- globulin with specific activity against purified colonization factor antigens can protect against oral challenge with entero- toxigenic Escherichia coli.

Topic 80
  Auto Label:        Antigens
  Descriptive Label: Antigens
  Keywords:          antigens new, antigen relation, immunisation antigens, lence active, viru- lence, relation viru-, antigens gl, determinants protective, gl, lence
  Summary:           Sjostedt A. Virulence determinants and protective antigens of Felix A.

Topic 81
  Auto Label:        Tuberculosis
  Descriptive Label: Tuberculosis – Migliori
  Keywords:          drug resistant, resistant, resistant tuberculosis, tuberculosis, drug, totally drug, totally, extensively drug, extensively, global control
  Summary:           1. Migliori GB, De Iaco G, Besozzi G, Centis R, Cirillo DM.

Topic 82
  Auto Label:        Tuberculosis
  Descriptive Label: Tuberculosis – Serum
  Keywords:          tuberculosis, antitoxic, phthisic tuberculosis, - phthisic, bactericidal, phthisic, p. treatment, report use, tuberculosis injections, injections immu-
  Summary:           The treatment of tuberculosis by injections of immu- nized blood serum. JAMA.

Topic 83
  Auto Label:        Immunodeficiency
  Descriptive Label: Immunodeficiency – Aids
  Keywords:          human immunodeficiency, immunodeficiency, immunodeficiency virus, notherapy, treatment advanced, antiviral therapy, advanced human, transfusions plasma, plasma rich, rich anti
  Summary:           Passive immu- notherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency. J Virol 2007;81(20):11016-

Topic 84
  Auto Label:        Pertussis
  Descriptive Label: Pertussis – Sulfadiazine
  Keywords:          pertussis, murine pertussis, toxin infect, lab, aerosol, experimental murine, katsampes, sulfadiazine, protective activities, activities mice
  Summary:           The therapeutic effect of sulfadiazine and immune rabbit serum in experimental murine pertussis. Yale J Biol Med.

Topic 85
  Auto Label:        Meningitis
  Descriptive Label: Meningitis
  Keywords:          plexus, cerebro spinal, amoss, meninges, spinal, cerebro, hl, infection 1917;25(4, choroid, poliomyelitic infection
  Summary:           Flexner S. Experimental cerebro-spinal meningitis and its serum treatment.

Topic 86
  Auto Label:        Streptococcus
  Descriptive Label: Streptococcus – Antibodies
  Keywords:          serotypes, protection multiple, reactivity, bodies protective, human anti-, wall, finger-, circulating human, antibodies reactivity, reactivity vivo
  Summary:           Human monoclonal antibodies to group B streptococcus. Reactivity and in vivo protection against multiple serotypes.

Topic 87
  Auto Label:        Clostridium
  Descriptive Label: Clostridium
  Keywords:          difficile, clostridium difficile, clostridium, toxins, induced mortality, toxins med, difficile toxins, 2015;83:822, molrine, broering nal
  Summary:           Monoclonal antibodies directed against toxins A and B prevent Clostrid- ium difficile-induced mortality in hamsters.

Topic 88
  Auto Label:        Immunoglobulin
  Descriptive Label: Immunoglobulin
  Keywords:          asthma, cd4 +, counts, cd4, +, asthma immunology, members, immunodeficiency committee, intravenous infected, infected children
  Summary:           intravenous immunoglobulin used in HIV-infected children with CD4+ counts of Orange JS, Hossny EM, Weiler CR, et

Topic 89
  Auto Label:        Proc
  Descriptive Label: Proc
  Keywords:          references chapter, chapter available, chapter, references, available, , , , , 
  Summary:           References for this chapter are available


Document-Level Assignments:
Doc 1: Topic 36 (Auto: Technology; Descriptive: Technology), Prob: 1.00000000
Doc 2: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 3: Topic 44 (Auto: Immunization; Descriptive: Immunization), Prob: 1.00000000
Doc 4: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 5: Topic 44 (Auto: Immunization; Descriptive: Immunization), Prob: 1.00000000
Doc 6: Topic 36 (Auto: Technology; Descriptive: Technology), Prob: 0.59380992
Doc 7: Topic 44 (Auto: Immunization; Descriptive: Immunization), Prob: 0.83938118
Doc 8: Topic 33 (Auto: 1932; Descriptive: 1932), Prob: 0.29127831
Doc 9: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 10: Topic 67 (Auto: Antibodies; Descriptive: Antibodies – Immunoglobulin), Prob: 1.00000000
Doc 11: Topic 67 (Auto: Antibodies; Descriptive: Antibodies – Immunoglobulin), Prob: 1.00000000
Doc 12: Topic 67 (Auto: Antibodies; Descriptive: Antibodies – Immunoglobulin), Prob: 1.00000000
Doc 13: Topic 39 (Auto: Influenza; Descriptive: Influenza – Immunity), Prob: 0.79389784
Doc 14: Topic 21 (Auto: Pertussis; Descriptive: Pertussis – Vaccination), Prob: 0.72807930
Doc 15: Topic 53 (Auto: Immunotherapy; Descriptive: Immunotherapy), Prob: 0.73039713
Doc 16: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 0.75980880
Doc 17: Topic 63 (Auto: Complement; Descriptive: Complement), Prob: 0.58585048
Doc 18: Topic 63 (Auto: Complement; Descriptive: Complement), Prob: 1.00000000
Doc 19: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 20: Topic 55 (Auto: Antibody; Descriptive: Antibody – Antibodies), Prob: 1.00000000
Doc 21: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 22: Topic 69 (Auto: Igg; Descriptive: Igg), Prob: 1.00000000
Doc 23: Topic 53 (Auto: Immunotherapy; Descriptive: Immunotherapy), Prob: 1.00000000
Doc 24: Topic 49 (Auto: Staphylococcal; Descriptive: Staphylococcal), Prob: 1.00000000
Doc 25: Topic 44 (Auto: Immunization; Descriptive: Immunization), Prob: 0.45797172
Doc 26: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 27: Topic 17 (Auto: Measles; Descriptive: Measles – Immunization), Prob: 0.58900720
Doc 28: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 29: Topic 30 (Auto: Measles; Descriptive: Measles – Immunoglobulin), Prob: 0.64612511
Doc 30: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 31: Topic 16 (Auto: Palivizumab; Descriptive: Palivizumab – Rsvs), Prob: 1.00000000
Doc 32: Topic 53 (Auto: Immunotherapy; Descriptive: Immunotherapy), Prob: 1.00000000
Doc 33: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 0.73408341
Doc 34: Topic 40 (Auto: Fever; Descriptive: Fever – Hemorrhagic), Prob: 1.00000000
Doc 35: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.46397159
Doc 36: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.80157768
Doc 37: Topic 56 (Auto: Lyme; Descriptive: Lyme), Prob: 1.00000000
Doc 38: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 39: Topic 13 (Auto: Antibody; Descriptive: Antibody – Influenzae), Prob: 0.45053150
Doc 40: Topic 43 (Auto: Influenzal; Descriptive: Influenzal), Prob: 1.00000000
Doc 41: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 42: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 43: Topic 39 (Auto: Influenza; Descriptive: Influenza – Immunity), Prob: 0.36973565
Doc 44: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 45: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.06686371
Doc 46: Topic 46 (Auto: Antibodies; Descriptive: Antibodies – Cows), Prob: 1.00000000
Doc 47: Topic 36 (Auto: Technology; Descriptive: Technology), Prob: 1.00000000
Doc 48: Topic 50 (Auto: Toxoplasmosis; Descriptive: Toxoplasmosis), Prob: 0.19718756
Doc 49: Topic 41 (Auto: Antibiotics; Descriptive: Antibiotics), Prob: 0.85349450
Doc 50: Topic 45 (Auto: Tularemia; Descriptive: Tularemia), Prob: 1.00000000
Doc 51: Topic 15 (Auto: Tuberculosis; Descriptive: Tuberculosis – Mycobacterium), Prob: 1.00000000
Doc 52: Topic 41 (Auto: Antibiotics; Descriptive: Antibiotics), Prob: 0.87528927
Doc 53: Topic 15 (Auto: Tuberculosis; Descriptive: Tuberculosis – Mycobacterium), Prob: 1.00000000
Doc 54: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 55: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 1.00000000
Doc 56: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 57: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 58: Topic 36 (Auto: Technology; Descriptive: Technology), Prob: 0.95775191
Doc 59: Topic 25 (Auto: Pseudomonas; Descriptive: Pseudomonas), Prob: 0.30378475
Doc 60: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 61: Topic 53 (Auto: Immunotherapy; Descriptive: Immunotherapy), Prob: 1.00000000
Doc 62: Topic 89 (Auto: Proc; Descriptive: Proc), Prob: 1.00000000
Doc 63: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 64: Topic 44 (Auto: Immunization; Descriptive: Immunization), Prob: 1.00000000
Doc 65: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 66: Topic 42 (Auto: Diphtheria; Descriptive: Diphtheria – Diphtherie), Prob: 1.00000000
Doc 67: Topic 76 (Auto: Diphtheria; Descriptive: Diphtheria – Antitoxins), Prob: 1.00000000
Doc 68: Topic 41 (Auto: Antibiotics; Descriptive: Antibiotics), Prob: 1.00000000
Doc 69: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 70: Topic 41 (Auto: Antibiotics; Descriptive: Antibiotics), Prob: 1.00000000
Doc 71: Topic 41 (Auto: Antibiotics; Descriptive: Antibiotics), Prob: 1.00000000
Doc 72: Topic 56 (Auto: Lyme; Descriptive: Lyme), Prob: 1.00000000
Doc 73: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 74: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 75: Topic 24 (Auto: Antiviral; Descriptive: Antiviral), Prob: 0.40515041
Doc 76: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 77: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 78: Topic 26 (Auto: Meader; Descriptive: Meader), Prob: 0.60068207
Doc 79: Topic 63 (Auto: Complement; Descriptive: Complement), Prob: 1.00000000
Doc 80: Topic 75 (Auto: Immun; Descriptive: Immun), Prob: 1.00000000
Doc 81: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 82: Topic 74 (Auto: Measles; Descriptive: Measles – Vaccine), Prob: 1.00000000
Doc 83: Topic 74 (Auto: Measles; Descriptive: Measles – Vaccine), Prob: 1.00000000
Doc 84: Topic 74 (Auto: Measles; Descriptive: Measles – Vaccine), Prob: 1.00000000
Doc 85: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 86: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 87: Topic 33 (Auto: 1932; Descriptive: 1932), Prob: 0.33831077
Doc 88: Topic 39 (Auto: Influenza; Descriptive: Influenza – Immunity), Prob: 1.00000000
Doc 89: Topic 39 (Auto: Influenza; Descriptive: Influenza – Immunity), Prob: 0.89624624
Doc 90: Topic 39 (Auto: Influenza; Descriptive: Influenza – Immunity), Prob: 1.00000000
Doc 91: Topic 21 (Auto: Pertussis; Descriptive: Pertussis – Vaccination), Prob: 0.23151581
Doc 92: Topic 21 (Auto: Pertussis; Descriptive: Pertussis – Vaccination), Prob: 0.27986793
Doc 93: Topic 21 (Auto: Pertussis; Descriptive: Pertussis – Vaccination), Prob: 0.48076810
Doc 94: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 95: Topic 21 (Auto: Pertussis; Descriptive: Pertussis – Vaccination), Prob: 0.71310448
Doc 96: Topic 21 (Auto: Pertussis; Descriptive: Pertussis – Vaccination), Prob: 1.00000000
Doc 97: Topic 21 (Auto: Pertussis; Descriptive: Pertussis – Vaccination), Prob: 1.00000000
Doc 98: Topic 70 (Auto: Antitiyphoid; Descriptive: Antitiyphoid), Prob: 1.00000000
Doc 99: Topic 70 (Auto: Antitiyphoid; Descriptive: Antitiyphoid), Prob: 1.00000000
Doc 100: Topic 56 (Auto: Lyme; Descriptive: Lyme), Prob: 1.00000000
Doc 101: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 102: Topic 47 (Auto: Vaccine; Descriptive: Vaccine – Vaccinia), Prob: 1.00000000
Doc 103: Topic 73 (Auto: Palivizumab; Descriptive: Palivizumab – Virus), Prob: 1.00000000
Doc 104: Topic 73 (Auto: Palivizumab; Descriptive: Palivizumab – Virus), Prob: 1.00000000
Doc 105: Topic 73 (Auto: Palivizumab; Descriptive: Palivizumab – Virus), Prob: 0.62594725
Doc 106: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 107: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 108: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 109: Topic 69 (Auto: Igg; Descriptive: Igg), Prob: 1.00000000
Doc 110: Topic 29 (Auto: Meningococcus; Descriptive: Meningococcus), Prob: 0.73095345
Doc 111: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 1.00000000
Doc 112: Topic 23 (Auto: Influenza; Descriptive: Influenza – Tection), Prob: 1.00000000
Doc 113: Topic 23 (Auto: Influenza; Descriptive: Influenza – Tection), Prob: 0.59209758
Doc 114: Topic 42 (Auto: Diphtheria; Descriptive: Diphtheria – Diphtherie), Prob: 1.00000000
Doc 115: Topic 37 (Auto: Sepsis; Descriptive: Sepsis), Prob: 1.00000000
Doc 116: Topic 17 (Auto: Measles; Descriptive: Measles – Immunization), Prob: 1.00000000
Doc 117: Topic 30 (Auto: Measles; Descriptive: Measles – Immunoglobulin), Prob: 1.00000000
Doc 118: Topic 17 (Auto: Measles; Descriptive: Measles – Immunization), Prob: 0.82558703
Doc 119: Topic 27 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Polio), Prob: 0.85853063
Doc 120: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 121: Topic 16 (Auto: Palivizumab; Descriptive: Palivizumab – Rsvs), Prob: 0.67160178
Doc 122: Topic 16 (Auto: Palivizumab; Descriptive: Palivizumab – Rsvs), Prob: 0.26048151
Doc 123: Topic 16 (Auto: Palivizumab; Descriptive: Palivizumab – Rsvs), Prob: 0.35121609
Doc 124: Topic 16 (Auto: Palivizumab; Descriptive: Palivizumab – Rsvs), Prob: 0.81977112
Doc 125: Topic 16 (Auto: Palivizumab; Descriptive: Palivizumab – Rsvs), Prob: 1.00000000
Doc 126: Topic 16 (Auto: Palivizumab; Descriptive: Palivizumab – Rsvs), Prob: 0.28379453
Doc 127: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 128: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 0.45689528
Doc 129: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 1.00000000
Doc 130: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 1.00000000
Doc 131: Topic 77 (Auto: Immunotherapie; Descriptive: Immunotherapie), Prob: 1.00000000
Doc 132: Topic 40 (Auto: Fever; Descriptive: Fever – Hemorrhagic), Prob: 1.00000000
Doc 133: Topic 40 (Auto: Fever; Descriptive: Fever – Hemorrhagic), Prob: 0.96866070
Doc 134: Topic 40 (Auto: Fever; Descriptive: Fever – Hemorrhagic), Prob: 1.00000000
Doc 135: Topic 62 (Auto: Reanalysis; Descriptive: Reanalysis), Prob: 0.87985719
Doc 136: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.33897755
Doc 137: Topic 40 (Auto: Fever; Descriptive: Fever – Hemorrhagic), Prob: 0.38572616
Doc 138: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.90670125
Doc 139: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.44535205
Doc 140: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 1.00000000
Doc 141: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.64461823
Doc 142: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.58607790
Doc 143: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 1.00000000
Doc 144: Topic 5 (Auto: Lassa; Descriptive: Lassa), Prob: 0.64461823
Doc 145: Topic 17 (Auto: Measles; Descriptive: Measles – Immunization), Prob: 0.65100515
Doc 146: Topic 17 (Auto: Measles; Descriptive: Measles – Immunization), Prob: 1.00000000
Doc 147: Topic 17 (Auto: Measles; Descriptive: Measles – Immunization), Prob: 0.72429471
Doc 148: Topic 30 (Auto: Measles; Descriptive: Measles – Immunoglobulin), Prob: 0.76881987
Doc 149: Topic 17 (Auto: Measles; Descriptive: Measles – Immunization), Prob: 0.76685574
Doc 150: Topic 33 (Auto: 1932; Descriptive: 1932), Prob: 1.00000000
Doc 151: Topic 61 (Auto: Influenza; Descriptive: Influenza – Pandemic), Prob: 1.00000000
Doc 152: Topic 61 (Auto: Influenza; Descriptive: Influenza – Pandemic), Prob: 1.00000000
Doc 153: Topic 61 (Auto: Influenza; Descriptive: Influenza – Pandemic), Prob: 1.00000000
Doc 154: Topic 61 (Auto: Influenza; Descriptive: Influenza – Pandemic), Prob: 0.49655082
Doc 155: Topic 23 (Auto: Influenza; Descriptive: Influenza – Tection), Prob: 1.00000000
Doc 156: Topic 13 (Auto: Antibody; Descriptive: Antibody – Influenzae), Prob: 0.37146167
Doc 157: Topic 23 (Auto: Influenza; Descriptive: Influenza – Tection), Prob: 0.26807957
Doc 158: Topic 78 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Globulin), Prob: 1.00000000
Doc 159: Topic 23 (Auto: Influenza; Descriptive: Influenza – Tection), Prob: 1.00000000
Doc 160: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 161: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 162: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 163: Topic 23 (Auto: Influenza; Descriptive: Influenza – Tection), Prob: 0.25127125
Doc 164: Topic 23 (Auto: Influenza; Descriptive: Influenza – Tection), Prob: 0.30820751
Doc 165: Topic 43 (Auto: Influenzal; Descriptive: Influenzal), Prob: 0.43518987
Doc 166: Topic 43 (Auto: Influenzal; Descriptive: Influenzal), Prob: 1.00000000
Doc 167: Topic 43 (Auto: Influenzal; Descriptive: Influenzal), Prob: 1.00000000
Doc 168: Topic 13 (Auto: Antibody; Descriptive: Antibody – Influenzae), Prob: 1.00000000
Doc 169: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 170: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 171: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 172: Topic 33 (Auto: 1932; Descriptive: 1932), Prob: 0.24383576
Doc 173: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 174: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 0.81909160
Doc 175: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 176: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 177: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 0.86583653
Doc 178: Topic 79 (Auto: Enteroviral; Descriptive: Enteroviral), Prob: 1.00000000
Doc 179: Topic 46 (Auto: Antibodies; Descriptive: Antibodies – Cows), Prob: 1.00000000
Doc 180: Topic 46 (Auto: Antibodies; Descriptive: Antibodies – Cows), Prob: 0.74110755
Doc 181: Topic 79 (Auto: Enteroviral; Descriptive: Enteroviral), Prob: 1.00000000
Doc 182: Topic 59 (Auto: Antitoxin; Descriptive: Antitoxin), Prob: 1.00000000
Doc 183: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 184: Topic 80 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 185: Topic 57 (Auto: Microbiol; Descriptive: Microbiol), Prob: 0.94983178
Doc 186: Topic 57 (Auto: Microbiol; Descriptive: Microbiol), Prob: 1.00000000
Doc 187: Topic 45 (Auto: Tularemia; Descriptive: Tularemia), Prob: 1.00000000
Doc 188: Topic 57 (Auto: Microbiol; Descriptive: Microbiol), Prob: 0.75384325
Doc 189: Topic 57 (Auto: Microbiol; Descriptive: Microbiol), Prob: 1.00000000
Doc 190: Topic 45 (Auto: Tularemia; Descriptive: Tularemia), Prob: 0.86545977
Doc 191: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.35053882
Doc 192: Topic 59 (Auto: Antitoxin; Descriptive: Antitoxin), Prob: 0.65764937
Doc 193: Topic 15 (Auto: Tuberculosis; Descriptive: Tuberculosis – Mycobacterium), Prob: 1.00000000
Doc 194: Topic 81 (Auto: Tuberculosis; Descriptive: Tuberculosis – Migliori), Prob: 1.00000000
Doc 195: Topic 81 (Auto: Tuberculosis; Descriptive: Tuberculosis – Migliori), Prob: 1.00000000
Doc 196: Topic 81 (Auto: Tuberculosis; Descriptive: Tuberculosis – Migliori), Prob: 1.00000000
Doc 197: Topic 15 (Auto: Tuberculosis; Descriptive: Tuberculosis – Mycobacterium), Prob: 1.00000000
Doc 198: Topic 82 (Auto: Tuberculosis; Descriptive: Tuberculosis – Serum), Prob: 1.00000000
Doc 199: Topic 82 (Auto: Tuberculosis; Descriptive: Tuberculosis – Serum), Prob: 1.00000000
Doc 200: Topic 82 (Auto: Tuberculosis; Descriptive: Tuberculosis – Serum), Prob: 1.00000000
Doc 201: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 1.00000000
Doc 202: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 1.00000000
Doc 203: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 204: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 0.53166804
Doc 205: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 206: Topic 83 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Aids), Prob: 1.00000000
Doc 207: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 208: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 209: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 210: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 1.00000000
Doc 211: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.10114200
Doc 212: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.63039815
Doc 213: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 214: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 215: Topic 52 (Auto: Anthrax; Descriptive: Anthrax), Prob: 0.89138303
Doc 216: Topic 52 (Auto: Anthrax; Descriptive: Anthrax), Prob: 1.00000000
Doc 217: Topic 52 (Auto: Anthrax; Descriptive: Anthrax), Prob: 1.00000000
Doc 218: Topic 52 (Auto: Anthrax; Descriptive: Anthrax), Prob: 0.73567005
Doc 219: Topic 10 (Auto: Botulism; Descriptive: Botulism), Prob: 1.00000000
Doc 220: Topic 10 (Auto: Botulism; Descriptive: Botulism), Prob: 0.24763318
Doc 221: Topic 10 (Auto: Botulism; Descriptive: Botulism), Prob: 0.06135021
Doc 222: Topic 10 (Auto: Botulism; Descriptive: Botulism), Prob: 1.00000000
Doc 223: Topic 10 (Auto: Botulism; Descriptive: Botulism), Prob: 0.84526596
Doc 224: Topic 10 (Auto: Botulism; Descriptive: Botulism), Prob: 0.25733233
Doc 225: Topic 10 (Auto: Botulism; Descriptive: Botulism), Prob: 0.61376002
Doc 226: Topic 76 (Auto: Diphtheria; Descriptive: Diphtheria – Antitoxins), Prob: 1.00000000
Doc 227: Topic 76 (Auto: Diphtheria; Descriptive: Diphtheria – Antitoxins), Prob: 1.00000000
Doc 228: Topic 42 (Auto: Diphtheria; Descriptive: Diphtheria – Diphtherie), Prob: 0.83819371
Doc 229: Topic 42 (Auto: Diphtheria; Descriptive: Diphtheria – Diphtherie), Prob: 1.00000000
Doc 230: Topic 42 (Auto: Diphtheria; Descriptive: Diphtheria – Diphtherie), Prob: 0.48917566
Doc 231: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 232: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 233: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 234: Topic 51 (Auto: Tetanus; Descriptive: Tetanus), Prob: 0.34464720
Doc 235: Topic 11 (Auto: Malaria; Descriptive: Malaria), Prob: 0.24213817
Doc 236: Topic 51 (Auto: Tetanus; Descriptive: Tetanus), Prob: 1.00000000
Doc 237: Topic 51 (Auto: Tetanus; Descriptive: Tetanus), Prob: 1.00000000
Doc 238: Topic 51 (Auto: Tetanus; Descriptive: Tetanus), Prob: 1.00000000
Doc 239: Topic 84 (Auto: Pertussis; Descriptive: Pertussis – Sulfadiazine), Prob: 1.00000000
Doc 240: Topic 84 (Auto: Pertussis; Descriptive: Pertussis – Sulfadiazine), Prob: 1.00000000
Doc 241: Topic 84 (Auto: Pertussis; Descriptive: Pertussis – Sulfadiazine), Prob: 1.00000000
Doc 242: Topic 26 (Auto: Meader; Descriptive: Meader), Prob: 1.00000000
Doc 243: Topic 26 (Auto: Meader; Descriptive: Meader), Prob: 1.00000000
Doc 244: Topic 26 (Auto: Meader; Descriptive: Meader), Prob: 1.00000000
Doc 245: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 246: Topic 56 (Auto: Lyme; Descriptive: Lyme), Prob: 0.97578386
Doc 247: Topic 48 (Auto: Papillomavirus; Descriptive: Papillomavirus), Prob: 1.00000000
Doc 248: Topic 48 (Auto: Papillomavirus; Descriptive: Papillomavirus), Prob: 1.00000000
Doc 249: Topic 48 (Auto: Papillomavirus; Descriptive: Papillomavirus), Prob: 0.81112804
Doc 250: Topic 87 (Auto: Clostridium; Descriptive: Clostridium), Prob: 1.00000000
Doc 251: Topic 87 (Auto: Clostridium; Descriptive: Clostridium), Prob: 1.00000000
Doc 252: Topic 87 (Auto: Clostridium; Descriptive: Clostridium), Prob: 1.00000000
Doc 253: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.15609698
Doc 254: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.06246234
Doc 255: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.96847034
Doc 256: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 257: Topic 46 (Auto: Antibodies; Descriptive: Antibodies – Cows), Prob: 1.00000000
Doc 258: Topic 45 (Auto: Tularemia; Descriptive: Tularemia), Prob: 1.00000000
Doc 259: Topic 13 (Auto: Antibody; Descriptive: Antibody – Influenzae), Prob: 1.00000000
Doc 260: Topic 13 (Auto: Antibody; Descriptive: Antibody – Influenzae), Prob: 0.60252057
Doc 261: Topic 13 (Auto: Antibody; Descriptive: Antibody – Influenzae), Prob: 1.00000000
Doc 262: Topic 43 (Auto: Influenzal; Descriptive: Influenzal), Prob: 0.63822676
Doc 263: Topic 15 (Auto: Tuberculosis; Descriptive: Tuberculosis – Mycobacterium), Prob: 1.00000000
Doc 264: Topic 15 (Auto: Tuberculosis; Descriptive: Tuberculosis – Mycobacterium), Prob: 1.00000000
Doc 265: Topic 15 (Auto: Tuberculosis; Descriptive: Tuberculosis – Mycobacterium), Prob: 1.00000000
Doc 266: Topic 29 (Auto: Meningococcus; Descriptive: Meningococcus), Prob: 1.00000000
Doc 267: Topic 29 (Auto: Meningococcus; Descriptive: Meningococcus), Prob: 1.00000000
Doc 268: Topic 29 (Auto: Meningococcus; Descriptive: Meningococcus), Prob: 0.46469871
Doc 269: Topic 85 (Auto: Meningitis; Descriptive: Meningitis), Prob: 1.00000000
Doc 270: Topic 29 (Auto: Meningococcus; Descriptive: Meningococcus), Prob: 1.00000000
Doc 271: Topic 85 (Auto: Meningitis; Descriptive: Meningitis), Prob: 1.00000000
Doc 272: Topic 25 (Auto: Pseudomonas; Descriptive: Pseudomonas), Prob: 0.59232711
Doc 273: Topic 25 (Auto: Pseudomonas; Descriptive: Pseudomonas), Prob: 0.80440446
Doc 274: Topic 25 (Auto: Pseudomonas; Descriptive: Pseudomonas), Prob: 1.00000000
Doc 275: Topic 37 (Auto: Sepsis; Descriptive: Sepsis), Prob: 0.15580865
Doc 276: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 277: Topic 25 (Auto: Pseudomonas; Descriptive: Pseudomonas), Prob: 1.00000000
Doc 278: Topic 25 (Auto: Pseudomonas; Descriptive: Pseudomonas), Prob: 0.47812148
Doc 279: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 280: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.06853284
Doc 281: Topic 80 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 282: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.10988857
Doc 283: Topic 70 (Auto: Antitiyphoid; Descriptive: Antitiyphoid), Prob: 1.00000000
Doc 284: Topic 34 (Auto: Shigellae; Descriptive: Shigellae), Prob: 1.00000000
Doc 285: Topic 34 (Auto: Shigellae; Descriptive: Shigellae), Prob: 1.00000000
Doc 286: Topic 34 (Auto: Shigellae; Descriptive: Shigellae), Prob: 1.00000000
Doc 287: Topic 34 (Auto: Shigellae; Descriptive: Shigellae), Prob: 0.08411222
Doc 288: Topic 34 (Auto: Shigellae; Descriptive: Shigellae), Prob: 0.68925515
Doc 289: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 290: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.53506548
Doc 291: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 1.00000000
Doc 292: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 1.00000000
Doc 293: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.57908375
Doc 294: Topic 49 (Auto: Staphylococcal; Descriptive: Staphylococcal), Prob: 0.48201838
Doc 295: Topic 49 (Auto: Staphylococcal; Descriptive: Staphylococcal), Prob: 1.00000000
Doc 296: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.63039815
Doc 297: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.76156717
Doc 298: Topic 86 (Auto: Streptococcus; Descriptive: Streptococcus – Antibodies), Prob: 1.00000000
Doc 299: Topic 72 (Auto: Streptococcal; Descriptive: Streptococcal – Antibody), Prob: 1.00000000
Doc 300: Topic 86 (Auto: Streptococcus; Descriptive: Streptococcus – Antibodies), Prob: 1.00000000
Doc 301: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 302: Topic 86 (Auto: Streptococcus; Descriptive: Streptococcus – Antibodies), Prob: 1.00000000
Doc 303: Topic 72 (Auto: Streptococcal; Descriptive: Streptococcal – Antibody), Prob: 1.00000000
Doc 304: Topic 72 (Auto: Streptococcal; Descriptive: Streptococcal – Antibody), Prob: 1.00000000
Doc 305: Topic 12 (Auto: Pneumonia; Descriptive: Pneumonia), Prob: 0.32140974
Doc 306: Topic 12 (Auto: Pneumonia; Descriptive: Pneumonia), Prob: 0.18127712
Doc 307: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 308: Topic 12 (Auto: Pneumonia; Descriptive: Pneumonia), Prob: 1.00000000
Doc 309: Topic 12 (Auto: Pneumonia; Descriptive: Pneumonia), Prob: 0.64162311
Doc 310: Topic 12 (Auto: Pneumonia; Descriptive: Pneumonia), Prob: 1.00000000
Doc 311: Topic 4 (Auto: Staphylococcus; Descriptive: Staphylococcus), Prob: 0.40430601
Doc 312: Topic 12 (Auto: Pneumonia; Descriptive: Pneumonia), Prob: 0.68135696
Doc 313: Topic 71 (Auto: Streptococcus; Descriptive: Streptococcus – Streptococci), Prob: 1.00000000
Doc 314: Topic 71 (Auto: Streptococcus; Descriptive: Streptococcus – Streptococci), Prob: 1.00000000
Doc 315: Topic 71 (Auto: Streptococcus; Descriptive: Streptococcus – Streptococci), Prob: 1.00000000
Doc 316: Topic 28 (Auto: Rubella; Descriptive: Rubella), Prob: 0.10794682
Doc 317: Topic 28 (Auto: Rubella; Descriptive: Rubella), Prob: 0.15773586
Doc 318: Topic 65 (Auto: Streptococcal; Descriptive: Streptococcal – Globulin), Prob: 1.00000000
Doc 319: Topic 65 (Auto: Streptococcal; Descriptive: Streptococcal – Globulin), Prob: 1.00000000
Doc 320: Topic 65 (Auto: Streptococcal; Descriptive: Streptococcal – Globulin), Prob: 1.00000000
Doc 321: Topic 59 (Auto: Antitoxin; Descriptive: Antitoxin), Prob: 0.90005744
Doc 322: Topic 59 (Auto: Antitoxin; Descriptive: Antitoxin), Prob: 1.00000000
Doc 323: Topic 33 (Auto: 1932; Descriptive: 1932), Prob: 1.00000000
Doc 324: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 1.00000000
Doc 325: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.19594775
Doc 326: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 0.36553818
Doc 327: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 1.00000000
Doc 328: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 329: Topic 3 (Auto: Pathogen; Descriptive: Pathogen), Prob: 1.00000000
Doc 330: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Antibodies), Prob: 1.00000000
Doc 331: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Antibodies), Prob: 1.00000000
Doc 332: Topic 64 (Auto: Bubonique; Descriptive: Bubonique), Prob: 1.00000000
Doc 333: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 334: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Antibodies), Prob: 0.80078145
Doc 335: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Antibodies), Prob: 1.00000000
Doc 336: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Antibodies), Prob: 0.37556201
Doc 337: Topic 12 (Auto: Pneumonia; Descriptive: Pneumonia), Prob: 0.13315811
Doc 338: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Antibodies), Prob: 0.52735994
Doc 339: Topic 14 (Auto: Vaccine; Descriptive: Vaccine – Antibodies), Prob: 0.48667947
Doc 340: Topic 64 (Auto: Bubonique; Descriptive: Bubonique), Prob: 1.00000000
Doc 341: Topic 64 (Auto: Bubonique; Descriptive: Bubonique), Prob: 1.00000000
Doc 342: Topic 18 (Auto: Hcv1; Descriptive: Hcv1), Prob: 0.73428305
Doc 343: Topic 18 (Auto: Hcv1; Descriptive: Hcv1), Prob: 0.73428305
Doc 344: Topic 18 (Auto: Hcv1; Descriptive: Hcv1), Prob: 0.57609689
Doc 345: Topic 19 (Auto: Antigenic; Descriptive: Antigenic), Prob: 0.55593490
Doc 346: Topic 19 (Auto: Antigenic; Descriptive: Antigenic), Prob: 0.70342761
Doc 347: Topic 79 (Auto: Enteroviral; Descriptive: Enteroviral), Prob: 1.00000000
Doc 348: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 0.18876790
Doc 349: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 0.94208103
Doc 350: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 1.00000000
Doc 351: Topic 80 (Auto: Antigens; Descriptive: Antigens), Prob: 1.00000000
Doc 352: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 0.40721380
Doc 353: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 0.78772399
Doc 354: Topic 7 (Auto: Cytomegalovirus; Descriptive: Cytomegalovirus), Prob: 1.00000000
Doc 355: Topic 18 (Auto: Hcv1; Descriptive: Hcv1), Prob: 1.00000000
Doc 356: Topic 18 (Auto: Hcv1; Descriptive: Hcv1), Prob: 1.00000000
Doc 357: Topic 18 (Auto: Hcv1; Descriptive: Hcv1), Prob: 1.00000000
Doc 358: Topic 54 (Auto: Ebola; Descriptive: Ebola), Prob: 1.00000000
Doc 359: Topic 54 (Auto: Ebola; Descriptive: Ebola), Prob: 1.00000000
Doc 360: Topic 54 (Auto: Ebola; Descriptive: Ebola), Prob: 1.00000000
Doc 361: Topic 54 (Auto: Ebola; Descriptive: Ebola), Prob: 0.31417725
Doc 362: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 0.92521683
Doc 363: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 0.79339417
Doc 364: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 365: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 366: Topic 19 (Auto: Antigenic; Descriptive: Antigenic), Prob: 0.24467538
Doc 367: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 1.00000000
Doc 368: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 0.49050733
Doc 369: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 0.83145775
Doc 370: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 1.00000000
Doc 371: Topic 58 (Auto: Hepatitis; Descriptive: Hepatitis – Hcv1), Prob: 0.20581719
Doc 372: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 0.80189747
Doc 373: Topic 58 (Auto: Hepatitis; Descriptive: Hepatitis – Hcv1), Prob: 1.00000000
Doc 374: Topic 58 (Auto: Hepatitis; Descriptive: Hepatitis – Hcv1), Prob: 1.00000000
Doc 375: Topic 18 (Auto: Hcv1; Descriptive: Hcv1), Prob: 0.54513993
Doc 376: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 0.62084627
Doc 377: Topic 58 (Auto: Hepatitis; Descriptive: Hepatitis – Hcv1), Prob: 1.00000000
Doc 378: Topic 68 (Auto: Glycoproteins; Descriptive: Glycoproteins), Prob: 1.00000000
Doc 379: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 380: Topic 11 (Auto: Malaria; Descriptive: Malaria), Prob: 0.20263134
Doc 381: Topic 89 (Auto: Proc; Descriptive: Proc), Prob: 1.00000000
Doc 382: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 0.62195811
Doc 383: Topic 60 (Auto: Herpes; Descriptive: Herpes), Prob: 0.62283699
Doc 384: Topic 60 (Auto: Herpes; Descriptive: Herpes), Prob: 1.00000000
Doc 385: Topic 60 (Auto: Herpes; Descriptive: Herpes), Prob: 1.00000000
Doc 386: Topic 88 (Auto: Immunoglobulin; Descriptive: Immunoglobulin), Prob: 1.00000000
Doc 387: Topic 20 (Auto: Hiviglob; Descriptive: Hiviglob), Prob: 0.70932517
Doc 388: Topic 60 (Auto: Herpes; Descriptive: Herpes), Prob: 1.00000000
Doc 389: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 390: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 0.37520289
Doc 391: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 0.80270461
Doc 392: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 393: Topic 83 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Aids), Prob: 1.00000000
Doc 394: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 0.41191190
Doc 395: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 1.00000000
Doc 396: Topic 20 (Auto: Hiviglob; Descriptive: Hiviglob), Prob: 0.56389564
Doc 397: Topic 83 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Aids), Prob: 1.00000000
Doc 398: Topic 48 (Auto: Papillomavirus; Descriptive: Papillomavirus), Prob: 1.00000000
Doc 399: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 400: Topic 20 (Auto: Hiviglob; Descriptive: Hiviglob), Prob: 1.00000000
Doc 401: Topic 31 (Auto: Antibody; Descriptive: Antibody – Encephalitis), Prob: 1.00000000
Doc 402: Topic 31 (Auto: Antibody; Descriptive: Antibody – Encephalitis), Prob: 1.00000000
Doc 403: Topic 22 (Auto: Fever; Descriptive: Fever – Immunity), Prob: 0.27580992
Doc 404: Topic 30 (Auto: Measles; Descriptive: Measles – Immunoglobulin), Prob: 0.88556044
Doc 405: Topic 30 (Auto: Measles; Descriptive: Measles – Immunoglobulin), Prob: 0.95090129
Doc 406: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 0.37469473
Doc 407: Topic 66 (Auto: Mumps; Descriptive: Mumps), Prob: 1.00000000
Doc 408: Topic 66 (Auto: Mumps; Descriptive: Mumps), Prob: 1.00000000
Doc 409: Topic 62 (Auto: Reanalysis; Descriptive: Reanalysis), Prob: 1.00000000
Doc 410: Topic 66 (Auto: Mumps; Descriptive: Mumps), Prob: 1.00000000
Doc 411: Topic 20 (Auto: Hiviglob; Descriptive: Hiviglob), Prob: 0.70932517
Doc 412: Topic 20 (Auto: Hiviglob; Descriptive: Hiviglob), Prob: 1.00000000
Doc 413: Topic 85 (Auto: Meningitis; Descriptive: Meningitis), Prob: 1.00000000
Doc 414: Topic 27 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Polio), Prob: 0.23239553
Doc 415: Topic 27 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Polio), Prob: 1.00000000
Doc 416: Topic 78 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Globulin), Prob: 1.00000000
Doc 417: Topic 78 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Globulin), Prob: 1.00000000
Doc 418: Topic 62 (Auto: Reanalysis; Descriptive: Reanalysis), Prob: 1.00000000
Doc 419: Topic 33 (Auto: 1932; Descriptive: 1932), Prob: 1.00000000
Doc 420: Topic 27 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Polio), Prob: 0.62608852
Doc 421: Topic 27 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Polio), Prob: 1.00000000
Doc 422: Topic 27 (Auto: Poliomyelitis; Descriptive: Poliomyelitis – Polio), Prob: 0.54052372
Doc 423: Topic 64 (Auto: Bubonique; Descriptive: Bubonique), Prob: 0.90300585
Doc 424: Topic 32 (Auto: Rabies; Descriptive: Rabies), Prob: 0.28998686
Doc 425: Topic 32 (Auto: Rabies; Descriptive: Rabies), Prob: 1.00000000
Doc 426: Topic 32 (Auto: Rabies; Descriptive: Rabies), Prob: 0.50822881
Doc 427: Topic 32 (Auto: Rabies; Descriptive: Rabies), Prob: 1.00000000
Doc 428: Topic 32 (Auto: Rabies; Descriptive: Rabies), Prob: 1.00000000
Doc 429: Topic 32 (Auto: Rabies; Descriptive: Rabies), Prob: 0.56946350
Doc 430: Topic 55 (Auto: Antibody; Descriptive: Antibody – Antibodies), Prob: 1.00000000
Doc 431: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 432: Topic 55 (Auto: Antibody; Descriptive: Antibody – Antibodies), Prob: 0.56041699
Doc 433: Topic 55 (Auto: Antibody; Descriptive: Antibody – Antibodies), Prob: 1.00000000
Doc 434: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 435: Topic 68 (Auto: Glycoproteins; Descriptive: Glycoproteins), Prob: 1.00000000
Doc 436: Topic 68 (Auto: Glycoproteins; Descriptive: Glycoproteins), Prob: 1.00000000
Doc 437: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 438: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 0.93012956
Doc 439: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 440: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 441: Topic 30 (Auto: Measles; Descriptive: Measles – Immunoglobulin), Prob: 1.00000000
Doc 442: Topic 28 (Auto: Rubella; Descriptive: Rubella), Prob: 1.00000000
Doc 443: Topic 28 (Auto: Rubella; Descriptive: Rubella), Prob: 1.00000000
Doc 444: Topic 28 (Auto: Rubella; Descriptive: Rubella), Prob: 0.52602183
Doc 445: Topic 28 (Auto: Rubella; Descriptive: Rubella), Prob: 1.00000000
Doc 446: Topic 19 (Auto: Antigenic; Descriptive: Antigenic), Prob: 1.00000000
Doc 447: Topic 19 (Auto: Antigenic; Descriptive: Antigenic), Prob: 1.00000000
Doc 448: Topic 19 (Auto: Antigenic; Descriptive: Antigenic), Prob: 0.81414638
Doc 449: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 1.00000000
Doc 450: Topic 20 (Auto: Hiviglob; Descriptive: Hiviglob), Prob: 1.00000000
Doc 451: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 0.73913937
Doc 452: Topic 2 (Auto: Hiv; Descriptive: Hiv), Prob: 0.95173764
Doc 453: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 1.00000000
Doc 454: Topic 75 (Auto: Immun; Descriptive: Immun), Prob: 1.00000000
Doc 455: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 456: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 0.68619501
Doc 457: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 1.00000000
Doc 458: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 1.00000000
Doc 459: Topic 6 (Auto: Immunodeficiency; Descriptive: Immunodeficiency – Macaques), Prob: 1.00000000
Doc 460: Topic 0 (Auto: Rotavirus; Descriptive: Rotavirus), Prob: 1.00000000
Doc 461: Topic 31 (Auto: Antibody; Descriptive: Antibody – Encephalitis), Prob: 1.00000000
Doc 462: Topic 31 (Auto: Antibody; Descriptive: Antibody – Encephalitis), Prob: 0.47973636
Doc 463: Topic 31 (Auto: Antibody; Descriptive: Antibody – Encephalitis), Prob: 0.68812236
Doc 464: Topic 47 (Auto: Vaccine; Descriptive: Vaccine – Vaccinia), Prob: 1.00000000
Doc 465: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 466: Topic 47 (Auto: Vaccine; Descriptive: Vaccine – Vaccinia), Prob: 0.91274130
Doc 467: Topic 19 (Auto: Antigenic; Descriptive: Antigenic), Prob: 0.31478074
Doc 468: Topic 47 (Auto: Vaccine; Descriptive: Vaccine – Vaccinia), Prob: 0.89629695
Doc 469: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 0.60108742
Doc 470: Topic 26 (Auto: Meader; Descriptive: Meader), Prob: 0.38940407
Doc 471: Topic 8 (Auto: Smallpox; Descriptive: Smallpox), Prob: 0.74694875
Doc 472: Topic 77 (Auto: Immunotherapie; Descriptive: Immunotherapie), Prob: 1.00000000
Doc 473: Topic 9 (Auto: Hepatitis; Descriptive: Hepatitis – Globulin), Prob: 0.35819845
Doc 474: Topic 77 (Auto: Immunotherapie; Descriptive: Immunotherapie), Prob: 1.00000000
Doc 475: Topic 31 (Auto: Antibody; Descriptive: Antibody – Encephalitis), Prob: 0.70171916
Doc 476: Topic 24 (Auto: Antiviral; Descriptive: Antiviral), Prob: 1.00000000
Doc 477: Topic 24 (Auto: Antiviral; Descriptive: Antiviral), Prob: 1.00000000
Doc 478: Topic 24 (Auto: Antiviral; Descriptive: Antiviral), Prob: 1.00000000
Doc 479: Topic 24 (Auto: Antiviral; Descriptive: Antiviral), Prob: 0.79459016
Doc 480: Topic 24 (Auto: Antiviral; Descriptive: Antiviral), Prob: 0.97108811
Doc 481: Topic 24 (Auto: Antiviral; Descriptive: Antiviral), Prob: 0.70986839
Doc 482: Topic 22 (Auto: Fever; Descriptive: Fever – Immunity), Prob: 0.25335928
Doc 483: Topic 22 (Auto: Fever; Descriptive: Fever – Immunity), Prob: 1.00000000
Doc 484: Topic 22 (Auto: Fever; Descriptive: Fever – Immunity), Prob: 1.00000000
Doc 485: Topic 22 (Auto: Fever; Descriptive: Fever – Immunity), Prob: 0.36984411
Doc 486: Topic 22 (Auto: Fever; Descriptive: Fever – Immunity), Prob: 1.00000000
Doc 487: Topic 22 (Auto: Fever; Descriptive: Fever – Immunity), Prob: 0.59582518
Doc 488: Topic 35 (Auto: Candidiasis; Descriptive: Candidiasis), Prob: 1.00000000
Doc 489: Topic 35 (Auto: Candidiasis; Descriptive: Candidiasis), Prob: 1.00000000
Doc 490: Topic 35 (Auto: Candidiasis; Descriptive: Candidiasis), Prob: 0.14474805
Doc 491: Topic 75 (Auto: Immun; Descriptive: Immun), Prob: 1.00000000
Doc 492: Topic 35 (Auto: Candidiasis; Descriptive: Candidiasis), Prob: 0.51016091
Doc 493: Topic 35 (Auto: Candidiasis; Descriptive: Candidiasis), Prob: 0.67526412
Doc 494: Topic 38 (Auto: Cryptosporidiosis; Descriptive: Cryptosporidiosis), Prob: 0.19965794
Doc 495: Topic 38 (Auto: Cryptosporidiosis; Descriptive: Cryptosporidiosis), Prob: 0.11440390
Doc 496: Topic 36 (Auto: Technology; Descriptive: Technology), Prob: 1.00000000
Doc 497: Topic 29 (Auto: Meningococcus; Descriptive: Meningococcus), Prob: 0.31858547
Doc 498: Topic 38 (Auto: Cryptosporidiosis; Descriptive: Cryptosporidiosis), Prob: 1.00000000
Doc 499: Topic 38 (Auto: Cryptosporidiosis; Descriptive: Cryptosporidiosis), Prob: 1.00000000
Doc 500: Topic 38 (Auto: Cryptosporidiosis; Descriptive: Cryptosporidiosis), Prob: 1.00000000
Doc 501: Topic 11 (Auto: Malaria; Descriptive: Malaria), Prob: 0.62381436
Doc 502: Topic 11 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 503: Topic 11 (Auto: Malaria; Descriptive: Malaria), Prob: 1.00000000
Doc 504: Topic 11 (Auto: Malaria; Descriptive: Malaria), Prob: 0.42575354
Doc 505: Topic 11 (Auto: Malaria; Descriptive: Malaria), Prob: 0.61382659
Doc 506: Topic 50 (Auto: Toxoplasmosis; Descriptive: Toxoplasmosis), Prob: 1.00000000
Doc 507: Topic 1 (Auto: Antibody; Descriptive: Antibody – Immunotherapy), Prob: 1.00000000
Doc 508: Topic 50 (Auto: Toxoplasmosis; Descriptive: Toxoplasmosis), Prob: 1.00000000
Doc 509: Topic 50 (Auto: Toxoplasmosis; Descriptive: Toxoplasmosis), Prob: 1.00000000
Doc 510: Topic 69 (Auto: Igg; Descriptive: Igg), Prob: 1.00000000
Doc 511: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 512: Topic 26 (Auto: Meader; Descriptive: Meader), Prob: 0.45801324
Doc 513: Topic 88 (Auto: Immunoglobulin; Descriptive: Immunoglobulin), Prob: 1.00000000
Doc 514: Topic 13 (Auto: Antibody; Descriptive: Antibody – Influenzae), Prob: 0.45053150
Doc 515: Topic 20 (Auto: Hiviglob; Descriptive: Hiviglob), Prob: 0.90128922
Doc 516: Topic 37 (Auto: Sepsis; Descriptive: Sepsis), Prob: 1.00000000
Doc 517: Topic 37 (Auto: Sepsis; Descriptive: Sepsis), Prob: 1.00000000
Doc 518: Topic 49 (Auto: Staphylococcal; Descriptive: Staphylococcal), Prob: 1.00000000
Doc 519: Topic 37 (Auto: Sepsis; Descriptive: Sepsis), Prob: 0.42819947
Doc 520: Topic -1 (Auto: Noise / Outlier; Descriptive: Noise / Outlier), Prob: 0.00000000
Doc 521: Topic 63 (Auto: Complement; Descriptive: Complement), Prob: 1.00000000
Doc 522: Topic 62 (Auto: Reanalysis; Descriptive: Reanalysis), Prob: 1.00000000
